Annoviant, Inc.
Alpharetta, GA
- UEI
- D9WMZ24BAKL5
- CAGE
- 844Z0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 260 Seale Ln, Alpharetta, GA 30022, USA
- Website
- annoviant.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Tgen [19-007542] | National Human Genome Research Institute (NIH) | $14,093 |
Grant awards
Similar vendors
About the company
Annoviant, Inc. is a for-profit, minority-owned small business that provides medical devices and related services to the federal government. Specifically, Annoviant develops regenerative valved conduits and related technologies to treat congenital heart defects in infants and children.
Through a 2019 prime federal contract with the National Institutes of Health, Annoviant provided services related to tissue generation. This $14,000 purchase order from the National Human Genome Research Institute was not set aside.
Annoviant has received over $5 million in National Institutes of Health grant funding to support the development, testing, and validation of its "TXGUARD" regenerative pulmonary valved conduit medical device. This includes a $4.5 million project grant from the National Heart, Lung, and Blood Institute to implement manufacturing quality control standards, test device performance and safety, and conduct preclinical trials. Annoviant also received a $328,000 National Institute of Biomedical Imaging and Bioengineering grant to develop a decellularized xenograft leaflet patch for pulmonary valve repair in children. Additionally, Annoviant was a subrecipient on a pediatric medical device grant from The Children's Hospital of Philadelphia.
SBA capabilities narrative
Combined team capabilities of over 50+ years of hands-on experience with innovation management, bio-technology, medical devices / technology development and commercialization.
Quick answers
Is Annoviant, Inc. registered in SAM.gov?
Yes. Annoviant, Inc.'s SAM.gov registration is active through May 21, 2027.
What is Annoviant, Inc.'s most recent federal award?
Annoviant, Inc.'s most recent federal grant award is Pulmonary valved conduit xenograft with regeneration potential - congenital heart disease affects approximately… (R44HL147771), from National Heart Lung and Blood Institute (NIH), on September 15, 2021.
On GovTribe
See Annoviant, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors